Buy Xtandi Online

Xtandi is an oral prostate cancer medicine containing enzalutamide, an androgen receptor inhibitor. It can be bought online with the dose or strength shown during ordering matched to your clinician’s directions. BorderFreeHealth offers US delivery from Canada for customers seeking transparent cash-pay access to this regulated cancer treatment.

Xtandi Price, Strength Choice, and Ordering Basics

Xtandi price can vary by strength, quantity, country of origin, and the current supply shown at checkout. Many customers look at Xtandi cost without insurance because advanced prostate cancer medicines can be expensive when paid fully out of pocket. The practical step is to match the strength and total quantity to the treatment directions you already use, then review the current cash-pay amount before placing the order.

Commonly referenced Xtandi presentations include 40 mg and 80 mg tablets, and some patients may also recognize older capsule references from treatment history or prior labels. The usual total daily enzalutamide amount described in labeling is 160 mg once daily, but your oncology team decides the regimen that fits your case. Do not change the number of tablets or the timing to reduce cost unless your clinician specifically instructs you to do so.

When comparing Xtandi Canadian pricing with U.S. cash-pay amounts, look beyond a single bottle amount. Consider the number of tablets, the total daily dose, how long the supply should last, and any handling or service fees shown during checkout. Products in this class are high-value medicines, so keep your medication list, diagnosis information, and current treatment directions organized before ordering.

Quick tip: Use the same strength wording from your treatment plan when selecting Xtandi, such as Xtandi 40 mg or Xtandi 80 mg tablets, so the daily total remains clear.

What Xtandi Treats

Xtandi is used for adults with certain types of prostate cancer. Labeling describes use in castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer, and professional labeling also includes certain non-metastatic castration-sensitive patients with biochemical recurrence at high risk for metastasis. These terms describe how prostate cancer behaves in relation to testosterone-lowering treatment and whether it has spread beyond the prostate.

Many people taking enzalutamide continue androgen deprivation therapy unless they have had surgical castration or their oncology team gives different instructions. Androgen deprivation therapy lowers testosterone, while Xtandi blocks androgen receptor signaling inside cancer cells. For condition background and treatment context, see our prostate cancer information.

Xtandi is not a chemotherapy pill. It is a hormonal pathway medicine, often called an androgen receptor inhibitor or anti-androgen. That difference matters because side effects, monitoring, and treatment sequencing can differ from traditional chemotherapy, but it does not make the medicine risk-free or interchangeable with other prostate cancer treatments.

How Enzalutamide Works

Enzalutamide blocks androgen receptor signaling. Androgens are hormones, including testosterone, that can stimulate prostate cancer cell growth. By interfering with this signal, Xtandi may help slow disease activity in labeled prostate cancer settings.

Effectiveness is assessed over time using clinical markers rather than a single daily feeling. Your care team may follow PSA, imaging results, symptoms, physical function, blood pressure, and tolerability. Some people feel little immediate change, while others notice fatigue or changes in stamina before any imaging or lab trend becomes clear.

Questions about “how effective Xtandi is” should be answered in the context of cancer stage, prior therapies, metastatic status, other conditions, and treatment goals. Clinical studies support labeled uses, but individual benefit varies. Ask your oncology team what outcome they are tracking for you, such as delaying progression, controlling symptoms, or supporting a broader treatment plan.

How to Take Xtandi Safely

Xtandi is taken by mouth once daily in the standard labeled regimen, with or without food. Swallow tablets whole with water. Do not crush, chew, split, dissolve, or open the medicine, because altering the tablet can change handling exposure and may affect how the dose is taken.

Try to take it at the same time each day. A consistent routine can reduce missed doses and makes it easier to connect any symptoms with timing. If you miss a dose, follow the patient information or your oncology team’s instructions; do not double up unless a healthcare professional tells you to.

If vomiting occurs after a dose, do not automatically take another tablet. Contact your care team if vomiting, appetite loss, dizziness, severe fatigue, or difficulty keeping medicines down becomes a pattern. These issues can affect treatment continuity and may need supportive care or dose evaluation.

Side Effects, Warnings, and Monitoring

Common side effects reported with Xtandi include fatigue, hot flushes, joint pain, back pain, headache, dizziness, decreased appetite, diarrhea, constipation, nausea, and swelling in the hands or feet. Fatigue can affect daily activity, driving, fall risk, and quality of life, so mention persistent tiredness early rather than waiting for the next routine appointment.

Serious but less common risks include seizures, posterior reversible encephalopathy syndrome, severe allergic reactions, falls, fractures, and cardiovascular events. Seek urgent medical care for a seizure, fainting, chest pain, severe shortness of breath, sudden confusion, severe headache, vision changes, or swelling of the face, lips, tongue, or throat. Blood pressure increases can occur, so monitoring is often part of ongoing care.

Tell your oncology team about a history of seizures, brain injury, stroke, uncontrolled high blood pressure, heart disease, falls, fractures, or medicines that lower the seizure threshold. Bone health may also need attention, especially if long-term androgen deprivation therapy is part of your plan. Calcium, vitamin D, weight-bearing activity, or bone-supporting medicines may be discussed when clinically appropriate.

Enzalutamide can interact with many medicines because it affects drug-metabolizing enzymes, including CYP3A4, CYP2C9, and CYP2C19 pathways. It may lower levels of some medicines, including certain anticoagulants, antiepileptics, immunosuppressants, antidepressants, and other sensitive substrates. Strong CYP2C8 inhibitors or inducers can also change enzalutamide exposure. Keep an updated list of all prescription medicines, over-the-counter products, vitamins, and supplements for every oncology and pharmacy review.

Women who are pregnant or may become pregnant should avoid handling broken or damaged tablets. Caregivers should handle intact tablets with dry hands and wash hands afterward. Because dizziness, fatigue, and seizure risk are possible, use caution with driving, ladders, machinery, and other activities where sudden impairment could harm you or others.

What to Avoid While Taking Xtandi

Avoid changing the dose schedule on your own, even when you feel well or side effects are frustrating. Xtandi works as part of a long-term cancer plan, and stopping suddenly can disrupt that plan. If side effects become difficult, your clinician may consider supportive measures, monitoring changes, treatment pauses, or other adjustments.

Avoid starting new medicines or supplements without checking for interactions. This includes herbal products, sleep aids, seizure medicines, blood thinners, and products promoted for prostate health. Supplements can still affect enzymes, bleeding risk, sedation, or blood pressure.

Limit situations that increase fall risk when you feel dizzy or unusually tired. Stand slowly, keep walkways clear, use footwear with traction, and ask about physical therapy or bone health if balance becomes a concern. Alcohol and sedating medicines may worsen dizziness or drowsiness for some people.

Storage, Travel, and Shipping

Store Xtandi at room temperature in the original container, away from excess moisture and heat. Keep the container closed when not in use, and store it out of reach of children and pets. Do not place tablets in unlabeled organizers unless your healthcare team says it is appropriate and safe for your household.

When traveling, keep Xtandi in carry-on baggage with the labeled container and a current medication list. Do not leave it in a hot car, checked luggage exposed to temperature extremes, or a bathroom with high humidity. Bring enough medicine for the trip and allow extra time for reorder planning.

Orders may use prompt, express shipping when appropriate for the order and service route. If you are organizing therapy around appointments, imaging, or travel, plan refills before the container runs low. For browsing by origin, our Canada-sourced medication section can help you understand related product sourcing categories.

Comparing Xtandi With Other Prostate Cancer Options

Advanced prostate cancer treatment often involves sequencing several therapies over time. Xtandi targets androgen receptor signaling directly. Abiraterone, darolutamide, chemotherapy, radiopharmaceuticals, immunotherapy, bone-supporting agents, and other approaches may be considered depending on disease stage, prior treatment, symptoms, lab findings, and other health conditions.

Choice of therapy is not based only on convenience or price. Drug interactions, seizure history, blood pressure, cardiovascular risk, steroid suitability, liver function, and cancer characteristics can all influence the decision. If a medicine in the same general treatment area appears less expensive, it may still be inappropriate for your specific plan.

For category browsing, see our cancer medications. For broader educational articles, the cancer articles section may help you prepare questions about screening, monitoring, and treatment discussions.

Questions to Ask Your Oncology Team

• Which prostate cancer stage or risk category is Xtandi being used to treat in my case?
• What daily total dose should I take, and which tablet strength matches it?
• Should I continue androgen deprivation therapy while taking enzalutamide?
• Which side effects should I report immediately?
• How often should blood pressure, PSA, imaging, or other monitoring be done?
• Do any of my medicines or supplements interact with Xtandi?
• What should I do if fatigue, dizziness, falls, or appetite loss affects daily life?
• How far ahead should I plan refills to avoid gaps during travel or appointments?

Authoritative Sources

DailyMed enzalutamide labeling search

FDA prescribing information archive

European Medicines Agency medicine summary

This content is for informational purposes only and is not a substitute for professional medical advice.